COMMUNIQUÉS West-GlobeNewswire

Dermatology Experts Present Latest Information at 2018 AAD Summer Meeting; American Academy of Dermatology

26/07/2018 - 14:00

CHICAGO, July 26, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Summer Meeting will take place from July 26 to 29 at the Hyatt Regency Chicago. The meeting will feature the latest information on skin [...]

The Joint Corp. to Host Conference Call on Thursday, August 9, to Discuss Second Quarter 2018 Results

26/07/2018 - 14:00

SCOTTSDALE, Ariz., July 26, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its second quarter 2018 financial results [...]

Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 2018

26/07/2018 - 14:00

BRIDGEWATER, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release [...]

Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New DischargeRx Program

26/07/2018 - 14:00

MIAMI, July 26, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced a partnership with Westchester General Hospital to implement [...]

Spine Injury Solutions Inc. (SPIN) Expands Its Affiliate Spine Diagnostic Practices To Include Concussion/Traumatic Brain Injury (TBI) Testing

26/07/2018 - 14:00

HOUSTON, July 26, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, financing and healthcare solution company announces after three months of research and testing [...]

aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference

26/07/2018 - 14:00

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Extendicare Announces Pending Departure of CEO

26/07/2018 - 14:00

MARKHAM, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) today announced that Tim Lukenda will be stepping down from his position as President and CEO, and Director [...]

Tetra Bio-Pharma Confirms Meetings With FDA

26/07/2018 - 14:00

Type B & C Meetings Move TBP Closer to Market Approval ORLEANS, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., (“ Tetra ” or the “ Company ”) a leader in cannabinoid-based drug discovery and [...]

Kalytera Therapeutics Announces Filing of Amended and Restated Short Form Prospectus

26/07/2018 - 14:00

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or “Kalytera”) (TSXV:KALY [...]

ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission

26/07/2018 - 13:58

Prior Approval Supplement (“PAS”) to Amend the Biologics License Application (“BLA”) for BIVIGAM ® is Supported by Data and Documentation Prepared Using ADMA’s Optimized IVIG Manufacturing P rocess Demonstrating Robust [...]

Inovalon Achieves Significant Advancement in Cloud Computing Capabilities

26/07/2018 - 13:55

Company Develops and Deploys Highly Elastic Cloud Container Orchestration Engine BOWIE, Md., July 26, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based [...]

Otonomy Initiates Phase 3 Clinical Trial of OTIVIDEX™ in Ménière’s Disease

26/07/2018 - 13:30

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced initiation of the additional [...]

Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated

26/07/2018 - 13:30

DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, announced the Impella 2.5 ® , Impella CP ® and Impella 5.0 ® [...]

Emblem Corp. Signs Letter of Intent to Acquire Natura Naturals

26/07/2018 - 13:04

Acquisition adds up to 70,000kg/yr capacity to support aggressive growth plan TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (OTCBB:EMMBF) (“Emblem” or the “Company”), announced today that it has [...]

Pain Therapeutics Reports Second Quarter 2018 Financial Results

26/07/2018 - 13:00

AUSTIN, Texas, July 26, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, today reported financial results for the second quarter ended June 30, 2018. Net loss was $2.5 million [...]

Asterias Biotherapeutics to Report Second Quarter 2018 Results on August 9, 2018

26/07/2018 - 13:00

FREMONT, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]

Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints

26/07/2018 - 13:00

BUFFALO, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Aclaris Therapeutics to Announce Second Quarter 2018 Financial Results on August 3, 2018

26/07/2018 - 13:00

WAYNE, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018

26/07/2018 - 13:00

- Initiation of Phase 1, first-in-human clinical trial of MCLA-158 in patients with solid tumors - - MCLA-128’s unique mechanism of action published in the scientific journal Cancer Cell - UTRECHT, The Netherlands, July [...]